MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Drug Delivery
Children
*Architects: Drug Delivery
*Architects: Drug Delivery (Biomaterial/Biopolymer)
*Architects: Drug Delivery (Catheter & Infusion Based)
*Architects: Drug Delivery (Inhalation, Nasal, Powder)
*Architects: Drug Delivery (Oral & Smart Pills)
*Architects: Drug Delivery (Transdermal Patches_Microneedles)
*Architects: Drug Delivery (Transmucosal)
*Architects: Drug Delivery (Viral Vector)
*Architects: Nanomedicine (Drug Delivery)
*Arrowhead, has a drug delivery platform called TRiM. TRiM stands for targeted RNAi Molecule platform
*Company with drug delivery technologies and drug candidates addressing rare and orphan diseases
*Driving Forces: BioPharmaceuticals _ Biotechnology, Genomics, Genetics, Bioinformatics, Biomanufacturing & Personalized Medicine, Drug Discovery, Development & Delivery
*Funding: Drug Delivery
*OptiNose develops nasal drug delivery technologies and combined drug and device therapies
*Pioneers: BioPharmaceuticals, Pharmacology, Drug Discovery, Development, Translation & Delivery
*Pioneers: Drug Delivery
*Pioneers: Image Guided Drug Delivery
*Purgo Scientific is a medical device company that has been formed to create a sustainable, localized drug delivery device to combat the biofilm infection crisis plaguing orthopedic surgery.
*Venture Capital Companies: Life Science & Healthcare Investors (Drug Delivery)
2009: Micromachined Passive Programmable Drug Delivery Systems:University of California, Irvine
2017: Alzheimer's Drug Delivery Foundation Issues RFP for Biomarker Studies
2022: Compact image-guided system for focal delivery of drugs and electric fields to the brain I. Weinberg, Weinberg Medical Physics, Inc.
2022: FDA_Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional (RFA-FD-22-016)
2023: Global Drug Delivery Partnering Terms and Agreements 2016-2023
2024: NIAID_Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed)
2024: Ophthalmic Drug Delivery
2024: Sustained-Release Implants A Targeted Approach To Drug Delivery
2024: Topic 471 Drug-Loaded Carrier Particles for Improved Oral Delivery for Colon Cancer Prevention
2025: 15th American Drug Delivery & Formulation, 15-16 September 2025, Boston, Massachusetts
2025: Smart Drug Delivery Systems Emerging Market Trends
A speciality drug delivery company
Clinical-stage medical device company focused on inhaled pulmonary drug delivery
Corinthian Ophthalmic is a medical device company developing ophthalmic drug delivery systems through manufacturer research.
Developing a Breakthrough Device that Combines Novel Biomaterials with Known Drug and Drug Delivery Technology in a Unique Design to Treat Cardiovascular Disease.
Drug Delivery & Packaging
Drug delivery and wound care medical device products
Drug delivery for diabetes
Drug Delivery Sonopheresis
Drug Delivery Technologies
Liposome-based drug delivery
Nanofiber Based Drug Delivery for Wound Healing-UVA
Nanoparticle based drug delivery & imaging markers
New Materials For Vaccine Development And Drug Delivery-Emory University
Non-invasive (needle-less) drug delivery patch to deliver drugs such as insulin--the patch could be developed to delivery emerge
Noninvasive Drug Delivery
Polymer-technologies for drug delivery and regenerative medicine with applications in orthopedics and spine
SMART Drug Delivery
Sustained-Release Drug Delivery
Targeted Drug Delivery
Theranostics
Transdermal drug delivery
Ultrasound drug delivery